DKMS, an international non-profit organisation dedicated to the fight against blood cancer, has opened the call for applications for the DKMS John Hansen Research Grant 2026. This prestigious award supports innovative research in blood stem cell transplantation and cell therapy for haematological diseases.

Each year, DKMS Stiftung Leben Spenden honours the legacy of Professor John Hansen by funding outstanding early-career scientists from around the world. For 2026, up to four researchers will be selected, each receiving €240,000 over three years to advance their projects.

The grant aims to strengthen the next generation of scientific leaders who are working to improve treatment outcomes and develop new therapies for patients affected by blood cancers and related conditions.

• Deadline: 20 November 2025

• Eligibility: Early-career scientists conducting research in the field of blood stem cell transplantation and cell therapy

• Funding: €240,000 per awardee, distributed across three years

Full application requirements and further details are available via the DKMS Professionals’ Platform or by contacting grant@dkms.org

SIOP encourages its members and networks to share this excellent funding opportunity widely within the paediatric oncology and broader scientific community. A summary flyer and press release are available from DKMS to support dissemination.

For any queries regarding the application process, please contact grant@dkms.org